A Comparison of Efficacy Between Recombinant Activated Factor VII (Aryoseven) and Novoseven in Patients With Hereditary FVIII Deficiency With Inhibitor.
Faranoush M, Abolghasemi H, Mahboudi F, Toogeh G, Karimi M, Eshghi P, Managhchi M, Hoorfar H, Dehdezi BK, Mehrvar A, Khoeiny B, Vaziri B, Kamyar K, Heshmat R, Baghaeipour MR, Mirbehbahani NB, Fayazfar R, Ahmadinejad M, Naderi M.
Faranoush M, et al. Among authors: mehrvar a.
Clin Appl Thromb Hemost. 2016 Mar;22(2):184-90. doi: 10.1177/1076029614555902. Epub 2014 Oct 24.
Clin Appl Thromb Hemost. 2016.
PMID: 25343955
Free article.
Clinical Trial.